New hope for cancer patients: drug may prevent chemo delays from low platelets
NCT ID NCT07408648
First seen Feb 14, 2026 · Last updated May 23, 2026 · Updated 12 times
Summary
This study tests a pill called hetrombopag to treat low platelets caused by chemotherapy in women with gynecological cancers like ovarian or cervical cancer. About 244 women will take the drug to see if it can safely raise their platelet counts and help them complete their next chemo cycle on time and at full dose. The goal is to reduce the need for platelet transfusions or treatment delays.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY INDUCED THROMBOCYTOPENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.